General Information of DTT (ID: TTPQJ7P)

DTT Name Ataxin-2 messenger RNA (ATXN2 mRNA) DTT Info
Gene Name ATXN2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
BIIB105 DMLMUK6 Amyotrophic lateral sclerosis 8B60.0 Phase 2 [1]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 ClinicalTrials.gov (NCT04494256) A Phase 1/2 Multiple-Ascending-Dose Study With a Long-Term Open-Label Extension to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Effect on Disease Progression of BIIB105 Administered Intrathecally to Adults With Amyotrophic Lateral Sclerosis With or Without Poly-CAG Expansion in the ATXN2 Gene. U.S.National Institutes of Health.